ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Eisai to sell anti-rheumatic injection in Japan biospectrumasia
May 13, 2019Eisai Co., Ltd. has entered into a license agreement with medac Gesellschaft für klinische Spezialpr?parate mbH (Medac) for the commercialization of its anti-rheumatic agent methotrexate (MTX) subcutaneous injection (pre-filled syringe) in Japan.
Pharma Sources Insight January 2025
